Released: ·Last reviewed: ·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
Dr. Jonathan Snipes, MD
Medical Reviewer · Physician (MD)
Dr. Jonathan Snipes, MD is one of the two medical reviewers named on every Transparent Peptide page, alongside Kim Callender, NP (FNP-BC). He reviews physician-level medical claims: indications, contraindications, dosing statements, trial results and regulatory status. His NPI record (1821250077) is listed in the CMS NPPES registry.
Credentials & verification
- Role
- Medical Reviewer (physician)
- NPI
- 1821250077 — listed in the CMS National Plan & Provider Enumeration System
- Review scope
- Physician-level medical claims on medication, peptide, safety and research pages.
- Since
- Named on every page from October 15, 2026; see COR-004.
Conflict disclosure
Dr. Snipes is not compensated based on any reviewed provider’s sales. The publisher’s relationship with NexLife is described on our conflicts-of-interest page.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.